Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › 2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof

2-H-indazole derivatives as cyclin-dependent kinase (CDK) inhibitors and therapeutic uses thereof

US Patent 9878994 · Granted Jan 30, 2018

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Protein degradation agent compound preparation method and application2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Treatment of EGFR mutant-related cancers using a combination of EGFR and CDK4/6 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Organophosphorus-substituted compounds as c-MET inhibitors and therapeutic uses 2025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025
Pharmaceutical formulations of N-(2-(2-(dimethylamino)ethoxy)-4-methoxy-5-((4-(12025